In: Journal of Infectious Diseases, ///-
|
In: Journal of Antimicrobial Chemotherapy, ///-
|
In: Journal of AIDS & clinical research, 2012, vol. S8:006, p. 1-10
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has been hampered by the HIV envelope (Env) heterogeneity that makes it difficult to induce neutralizing antibodies against Env proteins from different HIV clades. Several studies have indicated that gp120 Env protein sequence tends to change considerably during the course of HIV disease which...
|
In: Water Resources Management, 2014, vol. 28, no. 2, p. 407-424
|
In: Infection, 2011, vol. 39, no. 1, p. 91-91
|
In: Journal of NeuroVirology, 2008, vol. 14, no. 1, p. 78-84
|
In: Virchows Archiv, 2012, vol. 460, no. 4, p. 363-370
|
In: Clinical Infectious Diseases, 2012, vol. 54, no. 1, p. 131-140
|
In: Journal of Antimicrobial Chemotherapy, 2008, vol. 61, no. 4, p. 914-918
|
In: Clinical Infectious Diseases, 2012, vol. 54, no. 2, p. 282-284
|